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Abstract: In bacteria, the DnaG primase is responsible for synthesis of short RNA primers used to
initiate chain extension by replicative DNA polymerase(s) during chromosomal replication. Among
the proteins with which Escherichia coli DnaG interacts is the single-stranded DNA-binding protein,
SSB. The C-terminal hexapeptide motif of SSB (DDDIPF; SSB-Ct) is highly conserved and is known to
engage in essential interactions with many proteins in nucleic acid metabolism, including primase.
Here, fragment-based screening by saturation-transfer difference nuclear magnetic resonance
(STD-NMR) and surface plasmon resonance assays identified inhibitors of the primase/SSB-Ct
interaction. Hits were shown to bind to the SSB-Ct-binding site using 15N–1H HSQC spectra.
STD-NMR was used to demonstrate binding of one hit to other SSB-Ct binding partners, confirming
the possibility of simultaneous inhibition of multiple protein/SSB interactions. The fragment
molecules represent promising scaffolds on which to build to discover new antibacterial compounds.
Keywords: antibacterial agents; fragment-based screening; primase; protein–protein interactions; SSB
1. Introduction
Duplication of chromosomal DNA prior to cell division is a fundamental process in living cells.
During initiation of DNA replication in Escherichia coli, DnaB helicase is loaded with the assistance
of the helicase loader DnaC onto double-stranded DNA and unwinds it [1,2]. DnaB, through direct
physical interaction with DnaG primase, forms the primosome [3], which uses its primase activity to
synthesize short RNA primers essential for the function of DNA polymerase III [4,5].
DnaG is a DNA-dependent RNA polymerase [6]. In bacteria it is comprised of three distinct
domains: an N-terminal zinc-binding domain (ZBD) responsible for DNA template recognition [7],
a central catalytic domain (RNA polymerase domain, RPD) [8,9], and a C-terminal helicase-binding
domain (HBD or DnaGC), which is responsible for interaction with DnaB helicase and single-stranded
DNA-binding protein (SSB) [10–12]. The crystal and solution structures of DnaGC of E. coli were
determined by X-ray crystallography as a non-physiological domain-swapped dimer [13] and as a
monomer in solution by NMR spectroscopy [14].
SSB protects single-stranded DNA during DNA replication. It is an interaction hub known to bind
to more than 14 other proteins involved in various stages of DNA replication, repair, and recombination
through a highly conserved C-terminal hexapeptide motif (SSB-Ct, sequence: DDDIPF) [15,16]. SSB’s
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binding partners include DnaG [10,12], the Pol lll χ subunit [12,17–22], the PriA replication restart
helicase [23], and exonuclease I [24,25].
The SSB-Ct binding site in DnaGC has been identified by NMR. The binding pocket is formed by
basic residues K447, R452, and K518, as well as T450, M451, I455, and L519 [26]. Moreover, the DnaGC
point mutants K447A, T450A, R452A, and K518A dramatically attenuate SSB-Ct binding. Mutagenesis
and NMR experiments, in particular 15N–1H heteronuclear single-quantum correlation (15N–1H HSQC)
experiments suggested that the conserved R452 residue forms a salt bridge with the carboxylic acid of
the C-terminal Phe residue of the SSB-Ct, whereas the other positively charged residues around the
binding pocket interact with the negatively charged residues of SSB-Ct. The SSB-Ct binding pockets in
other SSB-binding proteins have characteristics in common with the binding pocket in DnaGC; e.g.,
those in ExoI [24], RecO [27], Pol lll χ [22], and PriA [23].
The SSB-Ct binding pockets in some or all of these proteins have been suggested to be very good
targets for development of new antibacterial agents because many of the interactions are essential for
bacterial survival and resistance to compounds that interfere with multiple interactions could not easily
develop by target mutagenesis [16]. This argument depends critically on a single compound mimicking
the SSB-Ct peptide sufficiently well that it is able to bind tightly to three or more essential binding
pockets that are lined with different residues and thus have structures that are more or less distinct.
The observed gross structural similarities among pockets in SSB-Ct binding partners, including the
ionic interaction with the C-terminal Phe and the basic rim that interacts with the acidic residues
suggest such compounds might exist, but the only useful way to establish this for sure is to quantify
the binding to multiple potential targets of compounds selected against one of them.
To begin the process of determining whether SSB-Ct binding pockets are actually suitable targets,
we report the use of fragment-based screening (FBS) to find compounds binding to E. coli DnaGC. FBS
uses small (<300 Da) compounds called “fragments” as starting points for drug discovery. Several
biophysical methods may be used in fragment screening [28]. Here, we report the use of surface
plasmon resonance (SPR) and NMR measurements to screen for binders that target the SSB-binding
pocket in DnaGC.
2. Results and Discussion
2.1. Screening of Fragment Libraries
An SPR competition assay (example in Figure S1a) was used as the first-pass screen. It identified
six small-molecule fragments that competed with immobilized SSB-Ct peptide for binding to a
N-terminally truncated DnaG protein missing just the ZBD; we call this protein DnaG-RCD, comprised
of the RPD and DnaGC domains. These fragments were validated by saturation-transfer difference
(STD) NMR [29], where transient binding of the ligand to the protein is detected by attenuation of
the ligand NMR spectrum (example in Figure S1b). In parallel with the confirmation of SPR hits,
cocktails encompassing the complete MIPS library of 1140 structurally diverse fragments [30] were
independently screened by STD-NMR. Fragments identified in cocktails were re-tested as pure ligands
in the STD-NMR assay. The hits identified were ranked according to STD signal intensity. In total,
56 fragments were identified as top hits (rank 3, clear hit, strong intensity difference) and 62 as
rank 2 (clear hit, moderate intensity) [30]. From the final STD rank 3 and 2 compounds together
(80 compounds), about 50 fragments were identified as “frequent hits” or “PAINS” [30] and were
excluded from further screening.
2.2. Validation of Fragment Binding by 2D NMR
Two-dimensional (2D) 15N–1H HSQC spectra of the uniformly 15N-labeled DnaGC domain were
employed to validate STD hits. Buffer conditions were optimized, and no major differences were
observed in recorded spectra of the protein alone compared to the original studies [13,14]. We were
able to assign some of the missing resonances for residues forming the SSB-Ct binding pocket in
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the spectrum of the apo-protein reported by Naue et al. [26]; i.e., those of K447, R448, T449, N511,
and N565. 15N–1H HSQC spectra were recorded on 0.1 mM solutions of 15N-DnaGC mixed with
compounds at 3.3 mM. The compounds were ranked according to the magnitude of the generated
weighted chemical shift perturbation (CSP; Section 3.5), and the best four were selected (Figure 1,
Figures S2a–c and S3a–d).
Antibiotics 2018, 7, x  3 of 12 
N565. 15N–1H HSQC spectra were recorded on 0.1 mM solutions of 15 -DnaGC  it  
  .  .  c   r  i  t  t  it  f t  ge er t  
i t                
i s c  3a– ). 
 
Figure 1. Superimposition of 15N–1H HSQC spectra of DnaGC. The protein spectrum in the absence 
of fragment in black is compared with its spectrum after addition of fragment 4 (structure shown) in 
red. Representative assignments of resonances that showed the highest weighted chemical shift 
perturbation (CSP) (Figure S3d) are shown. 
By monitoring the protein chemical shift and peak intensity changes upon addition of 
compound and mapping the CSP onto the protein surface, the location of the ligand-binding pocket 
could in each case be identified as the SSB-Ct binding pocket of DnaGC (Figure 2 and Figure S4). 
 
Figure 2. Modeled orientation of fragment 4. (a) The docked orientation of fragment 4 (green carbon 
atoms) in the single-stranded DNA-binding (SSB)-Ct binding pocket of DnaGC (gray carbon atoms). 
(b) A schematic representation of interactions between fragment 4 and its binding pocket. In all 
structural figures, the protein was visualized using visual molecular dynamics (VMD) [31]. 
Comparison of the four hits revealed some similar features such as the presence of indole groups 
in fragments 1 and 2 or an aliphatic thioether-linked extension in 2 and 3. In addition, three (1–3) 
have a carboxylate attached (Figure 3a) and fragment 4 has a 1H-tetrazole group, which is a 
carboxylate bioisostere [32]. Tetrazoles have pKa values comparable to carboxylic acids (~5) and are 
good hydrogen bond acceptors. Modeling studies suggest that deprotonated tetrazoles form stronger 
hydrogen bonds than carboxylate groups [33]. 
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a carboxylate attached (Figure 3a) and fragment 4 has a 1H-tetrazole group, which is a carboxylate
bioisostere [32]. Tetrazoles have pKa values comparable to carboxylic acids (~5) and are good hydrogen
bond acceptors. Modeling studies suggest that deprotonated tetrazoles form stronger hydrogen bonds
than carboxylate groups [33].
Affinity measurements of weakly binding ligands are challenging for most biophysical
techniques [34,35]. Nevertheless, binding affinities of fragments 1–4 can be roughly estimated to
be in the 1–3 mM range by NMR titration experiments that monitored the gradual change in chemical
shift of a few well-resolved resonances in HSQC spectra (Figure 3b).
2.3. Orientation of Identified Hits Using Molecular Docking
The docked structure of fragment 4 bound into DnaGC (Figure 2a) is in agreement with the
chemical shift perturbation (CSP) data. The tetrazole anion of 4 makes hydrogen bonds and/or a
salt bridge with the side chains of K447, T449, and R452. The phenyl ring appears likely to mimic
the last phenylalanine residue in the SSB-Ct peptide and makes hydrophobic interactions with P480,
G481, T515 and L519 in the binding site. Fluorine is a strong hydrogen-bond acceptor [36], and the
model suggests that there is a hydrogen bond to the para-fluoro group from the amide proton of
G481. Methyl groups from the side chains of L448, L455, T515, L516, and L519 also interact with the
para-fluoro group.
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∆δ, with incremental additions of ligand.
In the case of fragment 1, CSP-guided docking predicts that the carbonyl group interacts with
the side-chain of R452. The fragment orientation enables favorable contact of the free carboxylate of
the fragment and the positively charged side chain of K518 (Figure S4). Its improved binding affinity
(~1.1 mM) is most likely explained by its hydrophobic skeleton occupying the shallow binding pocket.
Comparison of fragment 1 with an analog where the carboxylate is substituted with a methyl group
gave fewer peak shifts in the HSQC spectrum, confirming that the carboxylic acid group improves the
binding (Figure S5).
Fragments 2 and 3 have similar aliphatic chains with thioether links to aromatic groups. As with
other fragments, the carboxylate moieties are predicted to form electrostatic and hydrogen bond
interaction, whereas the main chemical backbone mimics the phenylalanine residue in SSB-Ct.
Thioethers may have a strong influence on the conformation of aliphatic chains [37]. In the proposed
binding mode of fragment 3, the sulfur atom interacts with R452 while the carboxylate forms hydrogen
bonds with I455 and G481 (Figure S6).
One of the fragments tested, N-acetylated L-Phe, is expected to mimic the C-terminal residue
(F177) in the SSB-Ct peptide. STD and 15N–1H HSQC experiments confirmed the binding event (data
not shown). However, binding affinities measured in titration experiments monitored by HSQC
spectra showed that it has about two-fold lower affinity compared to other hits (3, 4). The modeled
Antibiotics 2018, 7, 14 5 of 12
orientations of the fragment show indeed that the phenyl ring forms hydrophobic contacts in the
binding site, and the carboxylate interacts with R452 (Figure S7). Substituting the carboxylate with a
1H-tetrazole ring, as found in fragment 4, increased the affinity 2-fold.
2.4. Fragment-to-Hit Optimization
With the knowledge that the tetrazole moiety might confer improved membrane-crossing
properties compared with carboxylates owing to its higher lipophilicity, fragment 4 (Figure 3a)
was chosen as a starting point for fragment-to-hit optimization. As docked into DnaGC, 4 has
suitable vectors for fragment growth. The in silico analog screen identified 10 tetrazole analogs
with favorable binding poses relative to the SSB-Ct peptide (not shown). Nevertheless, STD and
2D NMR experiments showed that most of these analogs did not bind to DnaGC. As an exception,
5-[2-fluoro-6-(4-fluorphenoxy)phenyl]tetrazol-1-ide (5) showed a STD signal and significant CSP in 2D
NMR experiments (Figure S3e). Mapping of the CSP on the protein surface allowed a binding pose of
compound 5 to be calculated (Figure 4).
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Figure 4. Visualization of binding of compound 5. (a) The lowest energy binding poses of 5 (green
carbon ato s) bound to DnaGC (gray carbon atoms). (b) Schematic representation of residues involved
in interactio with compound 5.
The observed NMR peak shifts were consistent with the docked orientation. The negatively
charged tetrazole is predicted to form favorable electrostatic and hydrogen bond interactions with the
side chains of K447 and R452. The methyl groups of L446, M451, L455, L484 T515 and L519 form a
hydrophobic pocket accommodating two aromatic rings of the compound. One of the fluorine atoms
is about 3 Å from the amide group of G481 while the second at the para-position of the phenoxy group
points out of the pocket toward K518. In the docked conformation, these fluorine atoms are involved
in hydrogen bond formation with these two residues (Figure 4). To test the docked orientation of 5,
1D 19F-NMR was carried out using a 20-fold excess of compound over protein. Fluorine signals were
broadened and shifted slightly downfield, confirming binding of 5 to DnaGC (Figure 5). Nevertheless,
the 3D NOESY-15N-HSQC spectrum failed to detect any protein–ligand NOEs.
Compound 5 was shown to bind to DnaGC with about a three-fold improved affinity compared
to the starting fragment 4, as measured by titration experiments monitored by 15N–1H HSQC spectra
(KD = 1.3 mM). Searching the ZINC database [38] for ligands structurally similar to 5 indicated that the
only available analog was 6. It is missing the halogen atoms and has a meta-phenoxy group (Figure 6).
The binding of 6 to DnaGC was also assessed by STD and 15N–1H HSQC experiments (Figure 6).
Compounds 5 and 6 showed similar patterns of CSPs (Figure S3e,f). Compounds that possess
similar protein-binding modes are known to induce similar CSPs [39]. Changes in the position of the
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phenoxy group in 6 relative to 5 increased the magnitude of the CSP as a result of a slightly improved
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Compound 6 was in turn docked to DnaGC and is predicted to form electrostatic interactions
with the side chains of K447, T449 ad R452 (Figure 7). The central aromatic ring sits in a hydrophobic
groove formed by M451, I455 and L484, while the phenoxy oxygen atom forms a hydrogen bond
with the side chain –OH of T515. In addition, the phenoxy ring forms a cation–π interaction with the
guanidinium group of R452 and hydrophobic contacts with the L446 and W522 side chains.
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To sample the impact of substituents at the para-position of the phenyl group of 4, additional
compounds were purchased (compounds 7 and 8; Figure 8). Molecular docking suggested that
para-substitutions might dramatically change the orientation of the tetrazole moiety in the binding
pocket, and STD and 15N–1H HSQC experiments showed that replacing the para-fluorine with a bulky
substituent reduced the CSPs substantially.
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Figure 8. Schematic representation of optimization of fragment 4. The red labeled groups were
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2.5. Binding of Compounds to Other SSB Partner Proteins
The fragments identified here and the first generation of optimized leads for DnaGC were tested
against other SSB-Ct binding partners including E. coli PriA, E. coli RNAse HI, and the χ subunit of
E. coli and Acinetobacter baumannii DNA polymerase III. STD-NMR was used to assess binding. All of
the identified frag e ts showed STD signals, confirming binding (Figure S8). Moreover, the docked
orientation of fragment 4 in the binding site of E. coli χ showed the possibility of hydrogen bonding
with the fluorine atom. 1D 19F NMR (Figure 9) demonstrated binding.
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3. Materials and Methods
3.1. Protein Expression and Purification
A phage λ-promoter plasmid (pZX1404) that directs overexpression of a protein comprising
the central and C-terminal domains of E. coli DnaG primase (residues 111–581, here called
DnaG-RCD) was constructed by cloning a PCR fragment between the BamHI and EcoRI sites of
vector pND706 [40]. PCR was performed using plasmid pPL195 [41] as template and the following
primers (restriction sites in italics): dnaG_RCD_F, 5′-GCGGGATCCTAAGAAGGAGATATACATATG
ACGCTTTATCAGTTGATG; dnaG_RCD_R, 5′-GCGGAATTCTTACTTTTTCGCCAGCTC C. The full
sequence of the gene encoding RCD was then verified by nucleotide sequence determination.
Another plasmid pZX1399 encoding amino acids 115–581 of E. coli DnaG was also constructed in
a similar manner. However, the protein was expressed in insoluble form, and therefore was not
used. Unlabeled DnaG-RCD and unlabeled and 15N-labeled DnaGC were expressed and purified as
described previously for DnaGC [42].
3.2. rag e t ibraries
e “first ass screen” fragment library (Zenobia Therapeutics, San Diego, CA, USA) was used for
the SPR competition assay. Each fragment (50 mM in DMSO) was diluted to 1 mM final concentration.
Fragment library members were tested for chip surface binding to eliminate false positives.
The Monash Institute of Pharmaceutical Science (MIPS) library comprised of around 1140
fragments purchased from Maybridge was used for STD-N R experiments. The in ividual fragments
were diluted in 2H6-DMSO to give ~660 mM final stock concentrations [30]. The fragments were mixed
in cocktails of up to 6 compounds with well-resolved resonances in their 1D 1H-NMR spectra.
3.3. SPR Competition Assay
SPR measurements utilized a Biacore T200 instrument (GE Healthcare, Little Chalfont, UK) at
20 ◦C to measure the competition of compounds for the DnaGC/SSB-Ct peptide interaction. The buffer
contained 10 mM HEPES (pH 7.4), 3 mM EDTA, 100 mM NaCl, 2% DMSO, 1 mM dithiothreitol
and 0.05% (v/v) surfa tant P20 (GE Healthcare). An N-terminally biotinylated SSB-Ct peptid
[Biotin-(Ahx)-GSAPS-NEP MDFDDDIPF; where Ahx is an amino-hexanoate spacer, foll wed by
the 16 C-terminal esidues of SSB highlig ted in bold] was mmo ilized onto a strep avidin (SA) chip
surface. RCD at 30 µM and fragments at 1 mM concentrations wer used in a SPR experiments.
Each s mple wa mixed for approximate y 15 min prior to measurements. Mixtures were injected
separ ely onto two flow cells, one of which served as a reference.
Prior to measure ents, each individual fr gm nt was tested for solubility and non-specific
binding to an unmodified u face at 1 mM concentration to eliminate false positive responses.
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Compounds that bound non-specifically to the chip surface were excluded from screening. A flow rate
of 5 µL/min was used during the 60 s injection and 60 s dissociation phases for all experiments.
3.4. Saturation-Transfer Difference (STD) NMR Spectroscopy
STD-NMR experiments were carried out using 5 µM unlabeled DnaG-RCD and mixtures of
6 fragments in each sample, at ~250 µM for each fragment. The sample volume was 500 µL with
98–99% 2H2O buffer containing 50 mM phosphate (pH 7.8), 50 mM NaCl and 1 mM dithiothreitol.
Spectra were recorded at 283 K using a Bruker Avance 600 MHz spectrometer (Bruker, Karlsruhe,
Germany) equipped with a cryoprobe. Saturation of protein was achieved with a 4 s Gaussian pulse
sequence train centered at −1 ppm. For reference spectra, a similar saturation pulse was applied
20 kHz off-resonance. A 20 ms spin-lock period was applied before acquisition to allow the residual
protein signals to decay. The STD experiments were recorded over 64 scans. All NMR data were
processed using TOPSPIN 3.1. Relative intensities were based on the most intense STD signal (Imax)
identified across all STD spectra. A positive STD signal was categorized as “strong”, “moderate” or
“weak” where the intensity was >50%, >25% or <25% of Imax, respectively [30].
3.5. 2D 15N–1H HSQC Spectra
Protein binding by compounds identified by SPR and STD screens was confirmed by recording
15N–1H HSQC spectra on uniformly 15N-labeled DnaGC (100 µM) in the presence of 3.3 mM
compounds (from 2H6-DMSO stocks) with HSQC buffer (50 mM MES pH 6.0, 60 mM NaCl, 1 mM
dithiothreitol) containing 3% 2H2O. The final volume of each sample was 150 µL. The recording
time was 30 min for each 15N–1H HSQC experiment. A standard pulse sequence was used for data
acquisition. Spectra were recorded at 298 K with a Bruker Avance 600 MHz NMR spectrometer
equipped with cryoprobe and auto-sample changer. Compounds were regarded as hits if chemical
shift perturbation was observed in the 15N–1H HSQC spectra. The spectra were processed with
TOPSPIN 3.1 and analyzed using CCPN [43]. Weighted CSP values [44] were calculated as
CSP = (∆δH2 + 0.2 ∆δN2)0.5
Binding affinities were estimated by incremental titration of fragments into protein, with recording
of a 15N–1H HSQC experiment at each concentration point. Compound solubilities were tested to
determine the highest concentrations of ligands used in assays. Equilibrium dissociation constants
from NMR titration data were derived using the “single site-specific binding with ligand depletion”
model in GraphPad Prism v.6.0 (La Jolla, CA, USA).
3.6. 19F-NMR Spectroscopy
1D 19F-NMR spectra were recorded on a Bruker Avance III 400 MHz NMR spectrometer (Bruker,
Karlsruhe, Germany) equipped with the two-channel BBO probe with z-gradient at 300 K. All 19F-NMR
spectra were recorded with 256 scans for fragment and complex samples sequentially. Fragments
dissolved in 2H6-DMSO were diluted in HSQC buffer to give final fragment and protein concentrations
of 1 mM and 50 µM, respectively.
3.7. Molecular Docking
AutoDock Tools 1.5.6 [45] was used to prepare protein [46] and ligand structures for docking.
The protonation state of the titratable groups in the protein were assigned at pH 7.0 using PROPKA
3.1 [47]. Polar hydrogen atoms and atom-based Gasteiger partial charges were added. Nonpolar
hydrogen atoms were merged with the parent atom. The DnaGC structure was taken from the
previously solved crystal structure (PDB ID: 1T3W) [13]. The protein was treated as a rigid body.
The CSP docking calculations were performed using AutoDock Vina 1.1.2 [45]. The calculations
utilized an exhaustiveness of 1024 with grid points separated by 1.0 Å and grid size large enough to
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include the SSB-Ct peptide binding site (16 × 16 × 14 Å). Ligand data were obtained from the ZINC
database of commercially available compounds [38].
4. Conclusions
Fragment-based screening has successfully identified compounds targeting the DnaG primase
and its SSB-Ct interaction. Compounds containing indole and 1H-tetrazole scaffolds were identified as
first-generation hits. Based on CSP-guided molecular modeling studies, they are involved in formation
of various electrostatic and hydrogen bond networks in the binding pockets, which makes them
promising starting points for further optimization. Initial in silico fragment-to-lead optimization
was carried out using the ZINC Database. Para-phenyl substituted tetrazoles were identified.
The observation that compounds selected for binding to the C-terminal domain of DnaG primase
also bind to other SSB-interacting proteins indicates that compounds may in future be derived that
bind to similar binding pockets in multiple protein targets, which is a prerequisite for development of
antibacterial compounds with a very low propensity for development of resistance.
Supplementary Materials: The following are available online at www.mdpi.com/2079-6382/7/1/14/s1,
Figure S1. Surface plasmon resonance (SPR) competition sensorgram for one of the SPR hits, and saturation
transfer difference (STD)-NMR spectrum of SPR hit D6; Figure S2. 15N–1H HSQC spectra of DnaGC protein with
and without fragment hits 1–3; Figure S3. Residue-specific weighted chemical shift perturbations induced in
15N-DnaGC by binding to compounds 1–6; Figure S4. Modeled orientation of fragment 1; Figure S5. Comparison
of chemical shift perturbation (CSP) induced by fragment 1 and compound L1C6; Figure S6. Modeled orientation
of fragment 3; Figure S7. Modeled orientation of N-acetyl-L-Phe (green carbon atoms) in the SSB-Ct binding
pocket of DnaGC (gray carbon atoms). Figure S8. STD NMR spectrum of fragment 4 with four SSB-Ct binding
partners other than DnaG primase.
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